Licitra L - Search Results

1

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.

Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli NA, Bossi P, Alfieri S, Serafini G, Colombo CB, Cicchetti A, Mira M, Licitra L, Fallai C, Crippa F, Orlandi E. Alessi A, et al. Among authors: licitra l. Radiol Med. 2019 May;124(5):414-421. doi: 10.1007/s11547-018-0980-6. Epub 2018 Dec 17. Radiol Med. 2019. PMID: 30560502

2

Cancer of the nasopharynx.

Licitra L, Bernier J, Cvitkovic E, Grandi C, Spinazzé S, Bruzzi P, Gatta G, Molinari R. Licitra L, et al. Crit Rev Oncol Hematol. 2003 Feb;45(2):199-213. doi: 10.1016/s1040-8428(01)00210-4. Crit Rev Oncol Hematol. 2003. PMID: 12604130 Review.

3

Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?

Licitra L, Bossi P, Locati L, Zunino F. Licitra L, et al. J Clin Oncol. 2004 Jan 15;22(2):377; author reply 377-8. doi: 10.1200/JCO.2004.99.219. J Clin Oncol. 2004. PMID: 14722048 No abstract available.

4

Head and neck tumors other than squamous cell carcinoma.

Licitra L, Locati LD, Bossi P, Cantù G. Licitra L, et al. Curr Opin Oncol. 2004 May;16(3):236-41. doi: 10.1097/00001622-200405000-00008. Curr Opin Oncol. 2004. PMID: 15069319 Review.

5

Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy.

Palazzi M, Guzzo M, Bossi P, Tomatis S, Cerrotta A, Cantú G, Locati LD, Licitra L. Palazzi M, et al. Among authors: licitra l. Tumori. 2004 Jan-Feb;90(1):60-5. doi: 10.1177/030089160409000114. Tumori. 2004. PMID: 15143974 Clinical Trial.

6

Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland.

Locati LD, Guzzo M, Bossi P, Massone PP, Conti B, Fumagalli E, Bareggi C, Cantù G, Licitra L. Locati LD, et al. Among authors: licitra l. Oral Oncol. 2005 Oct;41(9):890-4. doi: 10.1016/j.oraloncology.2005.04.014. Oral Oncol. 2005. PMID: 16043380

7

Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer?

Licitra L, Bossi P, Locati LD, Bergamini C. Licitra L, et al. J Clin Oncol. 2005 Oct 20;23(30):7757-8; author reply 7758-9. doi: 10.1200/JCO.2005.02.7854. J Clin Oncol. 2005. PMID: 16234549 No abstract available.

8

A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?

Licitra L, Bossi P, Locati LD. Licitra L, et al. Curr Opin Oncol. 2006 May;18(3):253-7. doi: 10.1097/01.cco.0000219254.53091.35. Curr Opin Oncol. 2006. PMID: 16552237 Review.

9

Advances in the changing patterns of aetiology of head and neck cancers.

Licitra L, Rossini C, Bossi P, Locati LD. Licitra L, et al. Curr Opin Otolaryngol Head Neck Surg. 2006 Apr;14(2):95-9. doi: 10.1097/01.moo.0000193170.23956.5f. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16552266 Review.

10

Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.

Perrone F, Suardi S, Pastore E, Casieri P, Orsenigo M, Caramuta S, Dagrada G, Losa M, Licitra L, Bossi P, Staurengo S, Oggionni M, Locati L, Cantu G, Squadrelli M, Carbone A, Pierotti MA, Pilotti S. Perrone F, et al. Among authors: licitra l. Clin Cancer Res. 2006 Nov 15;12(22):6643-51. doi: 10.1158/1078-0432.CCR-06-1759. Clin Cancer Res. 2006. PMID: 17121883 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters